Showing 51 - 60 of 253,676
Drug shortages are emerging as a major public health threat. Grave concern has been expressed by the medical community and government officials, and the crisis has been highlighted in recent media stories. Nevertheless, little has been written to date in the legal literature about the drug...
Persistent link: https://www.econbiz.de/10014173190
enforcement against in-transit generic pharmaceuticals. The analysis of the European border measures reveals that in addition to …
Persistent link: https://www.econbiz.de/10013070504
Persistent link: https://www.econbiz.de/10013433610
Background: Pharmaceutical expenditure grow strongly in most health care systems. Especially high prices of new drugs are perceived to be driver of growth which might threaten the sustainability of financing drugs. Objective: The study aims to analyse a) whether German health policies can...
Persistent link: https://www.econbiz.de/10013271336
pharmaceuticals. While political attention currently focuses on compulsory licensing under TRIPS, this article examines the article 27 … to exclude certain pharmaceuticals from patentability in order to enable affordable access for those affected by diseases …
Persistent link: https://www.econbiz.de/10014224715
This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...
Persistent link: https://www.econbiz.de/10013365665
Persistent link: https://www.econbiz.de/10013380684
Persistent link: https://www.econbiz.de/10013470005
Persistent link: https://www.econbiz.de/10014461499
Persistent link: https://www.econbiz.de/10014577795